chrisvoncsefalvay/vaers-outcomes huggingface dataset:
positive COVID; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (positive COVID) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (positive COVID). At the time of the report, COVID-19 (positive COVID) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: positive (Positive) Positive.         No Concomitant medications were reported. No treatment medications were reported. Patient's husband got Pfizer Vaccine and did not get COVID positive.  Company Comment: This is a spontaneous case concerning a patient of unknown age and gender, with no relevant medical history, who experienced the unexpected, non-serious, AESI event of COVID-19. The event occurred an unknown duration after the third dose of mRNA-1273 vaccine administered on an unknown date for the indication of COVID-19 vaccination. SARS-CoV-2 test done on an unknown date was positive. At the time of report outcome of the event was Unknown. Further details about the event are not provided. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report. Sender's Comments: This is a spontaneous case concerning a patient of unknown age and gender, with no relevant medical history, who experienced the unexpected, non-serious, AESI event of COVID-19. The event occurred an unknown duration after the third dose of mRNA-1273 vaccine administered on an unknown date for the indication of COVID-19 vaccination. SARS-CoV-2 test done on an unknown date was positive. At the time of report outcome of the event was Unknown. Further details about the event are not provided. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.
on 10/26 I had MRI cervical/thoracic spine that incidentally showed small bilateral pleural effusions of unknown clinical significance. Initially did not experience any symptoms but the following day began experiencing some intermittent sharp pains in lower right side of chest and then a more frequent dull pain on both sides of chest. I had an office visit with my doctor today 11/1. Cause of pleural effusions currently undetermined. CRP, ESR, CBC w/diff, d-dimer, ANA were ordered.
hi, I got Pfizer covid vaccine's first shot on 6/2 at 10:20 am. At around 10:30 pm, the left side of my face and facial bones became a bit stiff. Though I recovered next morning (on 6/3) but I still have a very slight numbness in my left jaw.  So I wanted to report this adverse effect.
This report described the occurrence of muscle spasms in a male patient who received Lyme disease vaccine recombinant OspA for prophylaxis. This report was received as part of litigation proceedings. Medical records were subsequently provided. The patient's attorney reported that three vaccinations were given, the last in 2001 according to the client. On 9/3/03, the patient's attorney alleged that the patient suffered muscle spasms, fatigue eye pain and pressure, blurriness of vision, and diaphoresis. The onset of this symptoms is not clear at this time. Treatment and outcomes of the alleged events were not reported. The following information was provided via medical records. The patient had a history of Lyme disease first diagnosed in 1991, and characterized by symptoms including severe arthritis of the lower extremities and neurological symptoms such as blurred vision, headaches, and occasional dizziness. Medical history also included palpitations, chest pressure on exertion, borderline mitral valve prolapse with mild mitral regurgitation, and trace pulmonic insufficiency. The most recent information received on 12/8/03 provided no information about the claimed events.
Information was received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received concerning the patient's past medical history, concurrent conditions, or concomitant medication. On or about 04-AUG-2015, the patient was inoculated at a pharmacy with ZOSTAVAX (lot number, dosage, and route of administration not provided), as recommended for routine adult health maintenance and for the prevention of shingles. The ZOSTAVAX vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster. On or about 29-DEC-2015, the patient was treated by a physician for the onset of a vesicular rash accompanied by weakened immune symptoms, which was diagnosed as herpes zoster, or shingles. The patient has experienced a persistent and actively blistering outbreak of shingles for more than two months, which only began to conclude on or about 16-FEB-2016. The patient has been prescribed FAMVIR for management of her persistent and painful symptoms. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
feeling dizzy; feeling weak; This case was reported by a nurse via sales rep and described the occurrence of dizziness in a 16-year-old female patient who received Men B NVS (Bexsero) for prophylaxis.   On an unknown date, the patient received Bexsero at an unknown dose. On an unknown date, less than a day after receiving Bexsero, the patient experienced dizziness and feelings of weakness. On an unknown date, the outcome of the dizziness and feelings of weakness were unknown.   It was unknown if the reporter considered the dizziness and feelings of weakness to be related to Bexsero.  Additional details were provided as follows: The patient felt dizzy after shot and also said she felt weak all afternoon after shot. The reporter agreed to follow up from GlaxoSmithKline (GSK).
This spontaneous report as received from a physician refers to unspecified number of patients. No information on their medical histories, concurrent conditions and concomitant therapies was provided. On an unknown date, the patients received doses of improperly stored (Oka/Merck) VARIVAX lot # K008823 (expiration date reported as 19-JUN-2016), lot # K021487 (expiration date reported as 03-NOV-2016) and lot # L002870 (expiration date reported as 27-JAN-2017) (doses, routes and sites of administration were not reported). No adverse effects were reported. Additional information has been requested.
This spontaneous report as received from a registered nurse refers to 4 patients of unknown age and gender. No information regarding the patient's medical history, concurrent conditions and concomitant medications was provided. Between 22-MAR-2016 and 23-MAR-2016, the patients might be vaccinated (nurse stated: "I don't know which ones were administered" but might included oral ROTATEQ with improperly stored doses of ROTATEQ oral liquid, lot# L029615 with expiration date 15-MAY-2017, and lot# L038534 with expiration date 19-AUG-2017, orally (dose was not reported). No adverse effect were reported. This is one of several reports from the same reporter. Additional information has been requested.
My arm started hurting very bad after about 2-3 hours. At the 12 hour mark from my vaccine (11:30PM), I started to have chills, a fever, and feel nauseous. Around 1 AM I started to vomit and this occurred for about 15 minutes, and then repeated again about an hour later. By the morning of the day after I was no longer vomiting or had chills but still had a fever. The most prominent symptoms on the day after my vaccine were extreme body aches and horrible joint pain. My hands and feet felt swollen and stiff. I had terrible pains and aches in my whole entire body. I was also very tired and still had a low grade fever. On the second day after the vaccine I had bad chest and neck pain and started to have a mild cough. By the third day after the vaccine, the chest pain was gone but still had bad neck pain and a headache that radiated through my skull.
This spontaneous report as received from a pharmacist refers to an unspecified patients of unknown age and gender. The patients medical history and current conditions were not provided. On an unknown dates, the patients were vaccinated with a 7 improperly stored doses of ZOSTAVAX lot # K018175, expiration date 10-JAN-2016, 0.65 ml, subcutaneous. No adverse effects reported. Additional information has been requested.
S/P 2nd vaccine. Pt stated he arrived at the monitor site, c/o feeling dizzy. Noted to be pale.  Patient stated he had thrown up earlier in the day (prior to the  vaccine). He was offered water, able to drink fluids, patients facial color returned to normal. Care assumed by paramedics.
Huge knot on patient's thigh where she received varicella shot.  She expressed not being able to walk.  She could walk, but it gave her great discomfort.  Over the coming days this developed into a horrible rash.  She now has a life threatening allergy to peanuts.
Within an hour of receiving the shot, my daughter started feeling sick. She complained of aches and i took her temperature (something the doctors / nurses had not done at the office prior to her physical and administering her shot) She had a low grade fever of 99.5. Within an hour after that her temperature was 100.3. We treated with Tylenol. At that time I noticed a spot on her throat - something that looked like cocksakie. Her fever got worse, she had chills, and sweats. She's finally went to sleep. Next day ( 8/3/ 18) fever stayed above 100, treated her with Tylenol. Sores in mouth worsened. Slept on and off all day.  Day 3 - fever and sores still existing. Treating with Tylenol to keep fever down. Trouble swallowing fluids and eating foods. In a lot of pain everywhere.
GARDASIL vaccine administered with no problems. When I was documenting the vaccine, it was noted that it expired 7-30-2018. I was administering 8-2-2018. I was decided after checking with supervisor that because it was expired, another dose should be given. GARDASIL, lot M042853 was administered in her right deltoid. No reactions were noted at this time.
Chills; Fatigue; body aches; went away when took ibuporfin; came back as soon it wore off, had to take 3 doses.
Local reaction - redness/swelling/inflammation on right deltoid w/ associated red swollen axillary lymphadenopathy.
Mom states at 4 mo check up, inc t of 106 rectally; no other sxs w/ 1st tetramune given at 2 mo check up;
Information has been received from a physician concerning a patient who on an unknown date was vaccinated with PNEUMOVAX 23. The physician reported that on an unspecified date after received PNEUMOVAX 23 the patient experienced swollen and redness at the injection site, and also had a fever that evening. It was noted that in the past this patient received PNEUMOVAX 23 and "had a reaction but not as severe as this time". At the time of the report, the outcome of the patient was unknown. Additional information has been requested.
Received 2nd dose of COVID-19 Moderna vaccine 03/10/2021. One hour after vaccination, pt called to report itching.
small gray dot on leg; Vaccine administered at inappropriate site; This case was reported by a nurse via sales rep and described the occurrence of skin discoloration in a 6-month-old patient who received DTPa-HBV-IPV (Pediarix) (batch number TS425, expiry date unknown) for prophylaxis.   Co-suspect products included dtpa-hbv-ipv vaccine pre-filled syringe device (Pediarix Pre-Filled Syringe Device) injection syringe for prophylaxis, HAEMOPHILUS B CONJUGATE VACCINE (TETANUS) (ACTHIB) for prophylaxis and PNEUMOCOCCAL 13 VALENT CONJUGATE VACCINE (PREVNAR) for prophylaxis.   Previously administered products included Pediarix with an associated reaction of skin discolouration (For tolerance of 2nd dose of Pediarix received on 28 Jul 2022 and refer case id US2022AMR149560) and Pediarix with an associated reaction of skin discolouration (For tolerance of 3rd dose of Pediarix received on 30 Sep 2022 and refer case id US2022AMR149561).   On 30th September 2022, the patient received the 3rd dose of Pediarix and Pediarix Pre-Filled Syringe Device. On an unknown date, the patient received ACTHIB and PREVNAR. On an unknown date, less than 2 weeks after receiving Pediarix and Pediarix Pre-Filled Syringe Device, the patient experienced skin discoloration and vaccine administered at inappropriate site. Rechallenge with Pediarix was positive. On an unknown date, the outcome of the skin discoloration was not recovered/not resolved and the outcome of the vaccine administered at inappropriate site was unknown.   It was unknown if the reporter considered the skin discoloration to be related to Pediarix and Pediarix Pre-Filled Syringe Device.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Linked case(s) involving the same patient:  US2022AMR149560, US2022AMR149561   Additional Information: GSK Receipt Date: 14-OCT-2022 Reporter's Comment: Prevnar and Acthib were also given with Pediarix in same leg so were not sure which vaccine caused the reaction. The faint grey dot was the adverse event that followed vaccination. It was unknown if the reporter considered the depigmentation spot to be related to Prevnar and Acthib. Additional Supportive Information: The case had been linked to US2022AMR148961, US2022AMR148962  and US2022AMR148919,reported by the same reporter, for a different patient.; Sender's Comments:  US-GSK-US2022AMR148962:same reporter US-GSK-US2022AMR148919:same reporter US-GSK-US2022AMR149560:same reporter US-GSK-US2022AMR149561:same reporter US-GSK-US2022AMR149551:same reporter
Patient came to the pharmacy today with a very large surface area surrounding site injection that was swollen and inflamed. She also had an area/patch of blistering. I advised patient to see her PCP.
Pt described shot it's self as painful. Arm swelled severely past elbow. Arm swelled w/redness. Low grade fever.
Vaccine received Thursday evening 5pm; fatigue all day Friday, but back to normal the following day. Sunday morning arm began feeling very sore. It is now the following Friday so 1 week later and arm still sore and there is a hard lump near injection site and bruised. Other than arm soreness for the entire week, I feel fine with no other adverse side effects.
This is a 71 y.o. female patient (COVID vaccinated) with a PMH notable for rheumatoid arthritis for which she is immunocompromised on rituximab and Plaquenil, TIA, sleep apnea who presents for evaluation of shortness of breath and weakness x1 week.  She has been tested for COVID-19 on 2 prior occasions both of which have been negative, 09/21/2021 and 09/28/2021.  Today, she presents feeling so weak and shortness of breath that she cannot function.    1st and 2nd vaccines given at Olmsted Medical Center No Lot number documented received 3rd shot 08/26/2021
Paresthesias involving arms, legs, feet, face, etc. Fluctuating severity, at times enough to keep patient from sleep. Gradually diminished in intensity over several weeks. Also, numbness of limbs on awakening and weakness of left arm after using the computer for a while. No demonstrable difficulty walking, running, although a sensation leg was not working right. No significant fatigue or lack of energy.  Normal neuro exam.
Tried taking a flu shot once 8 years ago and still suffer from neuropathy in feet as a result of that; Initial information was received on 07-Dec-2020 regarding an unsolicited valid serious social media case from a consumer (patient).  This case involves a 69 years old patient who still suffered from neuropathy in feet (taking a flu shot once 8 years ago), while he/she received INFLUENZA VACCINE.  Medical history, past medical treatments, vaccinations, concomitant medication and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE (produced by unknown manufacturer, batch number and expiration date were not reported) via an unknown route at an unknown administration site.  On an unknown date, the patient developed a serious neuropathy in feet (unknown latency) following the administration of INFLUENZA VACCINE. This event was assessed as medically significant.  The patient missed 2 days of work in the last 23 years.  Laboratory data was not reported.  It was reported that the patient had taken the vaccine 8 years ago and had still suffered from neuropathy in feet as a result of that.  It was not reported if the patient received any corrective treatment or not.  The patient was not recovered from the event at the time of reporting.  Batch number has been requested for suspect product for this case.; Sender's Comments: This poorly documented social media case concerns a 69 years old patient with who experienced neuropathy peripheral after vaccination with INFLUENZA VACCINE (unknown manufacturer). The time to onset is unknown. The patient's medical history, medical condition at time of vaccination, concomitant medication and lab test ruling out alternate etiologies were not reported. Based upon the reported information, the role of vaccine cannot be assessed.
Pt felt dizzy about 30 seconds after the pfizer vaccines was administered. Pt lost control bladder control as well. After moving patient  to lie on the floor and elevating her legs, patient regained consciousness. Blood pressure was checked - wnl - 107/80.  Paradmedics were called per pt's guardian request. Heart monitor showed normal heart rhythum and blood pressure.
VAXELIS administered since temperature excursion above 8.5° (10 mins)/Previous temperature excursion on 12-APR-22 above 8°C (10 mins); This non-serious spontaneous report with reference numbers 02197725 / 02197588, was received by partner on 05-JUL-2022 and forwarded on 06-JUL-2022 from a consumer.    The causal relationship between Vaxelis and the reported event "multiple doses of VAXELIS administered since temperature excursion" was assessed as not applicable due to the nature of the event.    Further information is expected.  FOLLOW-UP INFORMATION was received by a partner on 01-AUG-2022 and forwarded on 03-AUG-2022, from a HCP. The case is maintained as non-serious.  The reporter confirmed that there were no Adverse Events following Vaxelis administration to the patient.  Due to the nature of the event, the causality between the event "VAXELIS administered since temperature excursion above 8.5° (10 mins)/Previous temperature excursion on 12-APR-22 above 8°C (10 mins)" and Vaxelis remained not applicable.  For reference purposes this case is linked to MCM-003725, MCM-003726, MCM-003729, MCM-003734, MCM-003735, MCM-003737, MCM-003738, MCM-003739, MCM-003724, MCM-003741, MCM-003742, MCM-003743, MCM-003744, MCM-003747, MCM-003749, MCM-003751, MCM-003752, MCM-003753, MCM-003757, MCM-003759, MCM-003760, MCM-003761, MCM-003763, MCM-003766, MCM-003767, MCM-003769, MCM-003770, and MCM-003772, due to same reporter.  No further information is expected given that Vaxelis administration after temperature excursion caused no adverse events.
Pain at site of injection.  Swelling of  arm down to elbow, chills, aches especially in fingers and wrists, temp 100.2, nose bleed (minor).
Patient a PNEUMOVAX 23 vaccination and developed redness from her elbow to shoulder around the shot site beginning the evening of the shot. The redness area was getting smaller 2 days later when reported to us.
Next day arm pain, headache, muscle weakness, back pain . Day 6 noticed large inflamed area covering majority of deltoid area with x3 additional inflamed areas inferior to deltoid, hot to touch.
This spontaneous report as received from a physician refers to a patient of unknown age and gender. On an unknown date the patient was vaccinated with ZOSTAVAX (lot #, expiration date, route and anatomical location unspecified). The physician reported that the patient received an expired dose of ZOSTAVAX at an unspecified time and location. No adverse effect was reported. The patient's outcome was reported as recovered. Additional information is not expected.
Information has been received from a registered nurse concerning a 25 year old female with no pertinent medical history who on 06-Dec-2007 was vaccinated intramuscularly with a 0.5 ml dose of Gardasil (Lot #659437/1266U).  There was no concomitant medication.  On 06-Dec-2007, the patient developed generalized tingling and burning throughout her body including her genitals.  There was no laboratory or diagnostic tests performed.  The patient called the office.  At the time of the report the patient had not recovered.  Additional information has been requested.
He had diarrhea on 5/23/22-5/26/22. Then, on 5/24/22 he woke up in the middle of the night and vomited. I had to call the EMT on 6/5/22 to come check him out. On 6/9/22 his doctor found bilateral ear infection. I'm not entirely sure that it was an adverse event, but I thought I would mention this. They did have multiple negative COVID-19 test at this time, but later in May-early June our household tested positive for COVID-19. He still has a little cough and congestion, but he is feeling better now.
Approx. 15min. after injection  (08:45 am) client started complaining of trouble swallowing, tongue, lips and cheeks itching.  Complained of extreme fatigue, and syncope.  Approx. (9:03am) Obtained vital signs.  Still complaining of worsening symptoms about 2 min. later.  Called 911, administered 0.5mg Epi, IM to Rt. Deltoid, 50mg Benadryl to Rt Deltoid.  Ambulance arrived approx 5 min later, client was transported to hospital via ambulance at approx. (09:16 am).  She was alert and oriented, verbal when transported.
Pt began w/hives on face & buttocks; t102 went to 104; crying, HR 183 to 210; itchy; called MD instructed cold compresses to face, DPH; HR remained elevated for 7 hrs;
Headache; Backache; Body ache; Nausea; Vomiting; Diarrhea; Fever; seems like every night temperature goes up at night time mostly; This is a spontaneous report from a contactable consumer(patient). A patient of an unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot Number and expiration date were not reported), via unspecified route of administration on 07May2021 as first dose, single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient experienced headache, backache, body ache, nausea, vomiting, diarrhea and fever, it seems like every night the (temperature) goes up at night time mostly. Events were described as the worst side effects by the reporter. The patient was querying on how to know if was already been exposed to virus and would it be safe to get second dose out 3 weeks. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
This patient had firm local swelling at the site of first injection, he felt to be local fatty necrosis. Larger firmer swelling after the second injection. Both areas remained swollen with some liquification of nodulm swelling and finally with local scarring at the site after several months of swelling. No treatment given.
tiredness , stomach pain, shivering, fever  this lasted for about 35 hours.
Painful under arm under breast. small amount of redness at injection site. No fever took about 48 hours to resolve.
pt recv vax 28AUG95 & 30OCT96 pt devel an itchy rash w/30-50 vesiculopapular on trunk;there was no assoc fever;pt was seen by MD on 31OCT96 for exp;pt recovered;
Approximately nine days after receiving first dose injection patient developed itching in the arm that the injection was administered. The next day noticed redness in the upper part of the arm and continued itching. Redness and warmth are now spreading, but mainly on upper portion of left arm. On 3/24/2021 patient was prescribed Bactrim for the symptoms.